Drug Profile
GSK 2584786A
Alternative Names: Adjuvanted quadrivalent influenza vaccine - GSK; FLU D-QIV-AS03; GSK-2584786ALatest Information Update: 28 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 26 Oct 2016 Discontinued - Phase-II for Influenza virus infections (In children, In infants, Prevention) in Finland (IM)
- 26 Oct 2016 Discontinued - Phase-II for Influenza virus infections (In children, In infants, Prevention) in Spain (IM)